36E77618Q0067-A00001000.docx

5. PROJECT NUMBER (if applicable)

CODE

7. ADMINISTERED BY

2.

AMENDMENT/MODIFICATION NUMBER

CODE

6. ISSUED BY

8. NAME AND ADDRESS OF CONTRACTOR

4. REQUISITION/PURCHASE REQ. NUMBER

3. EFFECTIVE DATE

9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED

PAGE

OF PAGES

10A. MODIFICATION OF

CONTRACT/ORDER NUMBER

10B. DATED

BPA NO.

1. CONTRACT ID CODE

FACILITY CODE

CODE

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers

E. IMPORTANT:

is extended,

(a) By completing Items 8 and 15, and returning __________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY is not extended.

12. ACCOUNTING AND APPROPRIATION DATA

(REV.

11/2016) is required to sign this document and return ___________ copies to the issuing office.

is not, A. THIS CHANGE ORDER IS ISSUED PURSUANT TO:

Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITE M 10A.

15C. DATE SIGNED

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES

SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR

43.103(b).

RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes r eference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

C. THIS SUPPLEMENTAL AGREEMENT IS

ENTERED INTO

PURSUANT TO AUTHORITY OF:

D. OTHER

BY

Contractor

16C. DATE SIGNED

14.

DESCRIPTION OF AMENDMENT/MODIFICATION

16B. UNITED STATES OF AMERICA

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME

AND TITLE OF SIGNER

16A. NAME AND TITLE OF CONTRACTING OFFICER

15B. CONTRACTOR/OFFEROR

STANDARD FORM 30

PREVIOUS EDITION NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.243 (Type or print) (Type or print) (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

(Number, street, county, State and ZIP Code) (If other than Item 6) (Specify type of modification and authority) (such as changes in paying office, appropriation date, etc.)

(If required)

(SEE ITEM 11)

(SEE ITEM 13)

(X)

CHECK

ONE

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

11. THIS ITEM ONLY APPLIES TO AMENDMENTS

OF SOLICITATIONS

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

(Signature of person authorized to sign) (Signature of Contracting Officer) A00001 06-14-2018 554-18-1-1889-0020

LV38

36E776 Department of Veterans Affairs Program Contracting Activity Central 6150 Oak Tree Blvd, Suite 300 Independence OH 44131 36E776 Department of Veterans Affairs Program Contracting Activity Central 6150 Oak Tree Blvd, Suite 300 Independence OH 44131 To all Offerors/Bidders

36E77618Q0067 06-08-2018

X X X X

The purpose of this amendment is to answer vendor questions in response to solicitation 36E77618Q0067.

Please see attached for questions and answers. The due date for receipt of q uotes has not been extended and remains June 22, 2018 at 10:00 AM (Eastern).

MICHELLE RHODES

CONTRACTING OFFICER

CONTINUATION PAGE

Solicitation 36E77618Q0067 Infusion Pump System and Pump Server Upgrade Project No. LV38 – Denver Activation

Vendor Questions and Answers

1. QUESTION: When you say initial outfitting and activation does not mean there are no pumps in place already in the building?

ANSWER: The VA ECHCS currently uses the CareFusion Alaris system and this acquisition requires the delivery and upgrade of the system for use in the new facility. Please see solicitation “ATTACHMENT 2 – JA Brand Name FAR 13.501 v3.0 – LV38 Infusion Pumps – Redacted.”

2. QUESTION: In the second paragraph it says software and hardware refresh, when it come to the refresh if the Alaris is already being used would you accept an equal as the hardware refresh?

ANSWER: An “or equal” cannot be accepted for this requirement. Please see solicitation “ATTACHMENT 2 – JA Brand Name FAR 13.501 v3.0 – LV38 Infusion Pumps – Redacted” for an explanation of why the Government is requiring the name brand Alaris system.

3. QUESTION: Does the VA ECHCS Currently use the Alaris EtCO2 modules integrated with the Alaris PCA pumps in their current medical practice on patients?

ANSWER: Yes, the VA ECHCS is currently using the Alaris EtCO2 modules integrated with the PCA pumps in their current medical practice on patients.

4. QUESTION: Does the VA ECHCS currently use the Alaris Syringe module in their current medical practice on patients?

ANSWER: Yes, the VA ECHCS is currently using the Alaris Syringe modules in their current medical practice on patients.

5. QUESTION: We understand that the Clinical Information System (CIS-ICU) is being expanded into the medical surgical area. Why is the VA ECHCS not considering IV pump interoperability with CliniComp Essentris?

ANSWER: The current workflow with CIS-ICU does not involve infusion devices. As we move to the new facility, the same workflow is going to be used, as the same interfaces were purchased in that project.

6. QUESTION: When does the VA ECHCS expect to go live with Cerner for their Electronic Medical Record system replacing VistA?

ANSWER: The timeline for the replacement of VistA with Cerner for the electronic medical records system does not impact the requirement for the Alaris infusion pump system and pump server upgrade.

7. QUESTION: One of the justifications for staying with BD Alaris is the number of IV pumps to replace would be less by a count of 25. If another vendor was to bid for an extra 25 infusion pumps but the overall cost to replace the infusion system was less, how would that justification still apply?

ANSWER: The infusion pump system needs to include all kinds of pumps to include PCA, Syringe, and Large Volume as detailed in Section 5 of the solicitation “ATTACHMENT 2 – JA Brand Name FAR 13.501 v3.0 – LV38 Infusion Pumps – Redacted.” Uniformity of infusion therapy systems, and the components of those systems, are essential for patient safety and research supports uniformity of infusion therapy systems significantly increases patient safety. Please see “ATTACHMENT 2 – JA Brand Name FAR 13.501 v3.0 – LV38 Infusion Pumps – Redacted” for the specific research and data.

8. QUESTION: Can you un-redact the financial justification so it can be seen if the VA ECHCS is actually saving money by not going with a different infusion system?

ANSWER: We cannot un-redact the financial justification.

9. QUESTION: The justification for patient safety about not having two separate systems does not apply if another vendor replaces all large volume infusion and PCA pumps at the VA ECHCS. If the VA ECHCS is concerned about patient safety, explain how it would not make clinical sense to at least look at an infusion system that has an FDA 510K approval that is 10 years newer than their current system and can interface with the current CIS for the ICU and Med Surg to automate infusion programming and critical care flow sheet documentation?

ANSWER: In addition to Large Volume and PCA, the Alaris system utilizes EtCO2 and Syringe. VA Patient Safety has said the EtCO2 integration to the PCA is critical to ensure the infusion stops with low EtCO2 readings. Please refer to solicitation “ATTACHMENT 2 – JA Brand Name FAR 13.501 v3.0 – LV38 Infusion Pumps – Redacted” for the specific research and data.

10. QUESTION: Has the VA ECHCS asked their current vendor (BD) if they plan to work with CliniComp to provide interoperability with the Alaris System?

ANSWER: This is not a requirement for this acquisition.

11. QUESTION: What actions is the VA ECHCS taking to overcome future barriers to competition for the requirements in this solicitation?

ANSWER: Please see Section 11 of the solicitation “ATTACHMENT 2 – JA Brand Name FAR 13.501 v3.0 – LV38 Infusion Pumps – Redacted” for the actions VA ECHCS will be taking to overcome future barriers to competition. Further, Section 5 of the solicitation “ATTACHMENT 2 – JA Brand Name FAR 13.501 v3.0 – LV38 Infusion Pumps – Redacted” explains the rationale for the use of the brand name.

12. QUESTION: Why did the VA ECHCS not give other vendors a chance to present their infusion system solution?

ANSWER: Current medical research documented in solicitation “ATTACHMENT 2 – JA Brand Name FAR 13.501 v3.0 – LV38 Infusion Pumps – Redacted” as well as GAO decisions B-411904 and B-259010 supports standardization of systems as a basis for a sole source award. This requirement will be competed but the approved Brand Name Justification and Approval in accordance with FAR 13.106-1(b)(2) permits other than full and open competition for the acquisition of commercial items conducted pursuant to FAR Subpart 13.5. Rationale is provided in solicitation “ATTACHMENT 2 – JA Brand Name FAR 13.501 v3.0 – LV38 Infusion Pumps – Redacted.”

13. QUESTION: How is ECHCS’s current compliance with respect to changing the drug library when a patient transfers from one care area to another?

ANSWER: This is a clinical workflow question and does not relate to the procurement of the equipment in this requirement.

End of Document